推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
特朗普访华,施展欧盟很愚蠢! 特朗普访华很得胜,但目下欧盟又尬在那了,因为他们还
关于OD
中新经纬5月18日电(董湘依)跟着好意思元体系里面实体经济的失衡,东说念主民币外
关于OD
开元棋牌官方网站入口 直播吧5月15日讯中超第12轮,北京国安主场4-2驯顺青岛
日前,国乒队员牛冠凯在酬酢平台告示喜信,晒出共创视频,与竹马之交的退役畅通员段冬
全球知谈,手机圈这两年的竞争还是到了尖锐化的进度,各家子品牌和性能线齐在拚命堆电
凡是稍稍可爱外出游玩的东说念主,齐不得不感喟我们国度的气候有多耐看。从东北漫天飞

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
carcinoma in situ ofbladder相关文献:
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel.
Am J Surg Pathol. 2024 Jan 1;48(1):e11-e23. doi: 10.1097/PAS.0000000000002077. Epub 2023 Jun 29.
PMID:37382156
Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guerin immunotherapy.
Subiela JD, Rodríguez Faba Ó, Aumatell J, Calderón J, Mercadé A, Balañà J, Esquinas C, Algaba F, Breda A, Palou J.
BJU Int. 2022 Apr;129(4):542-550. doi: 10.1111/bju.15567. Epub 2021 Aug 23.
PMID:34375494
Carcinoma in situ of the bladder.
Hudson MA, Herr HW.
J Urol. 1995 Mar;153(3 Pt 1):564-72. doi: 10.1097/00005392-199503000-00002.
PMID:7861485
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ.
Straccia P, Fiorentino V, Martini M, Pierconti F.
Actas Urol Esp (Engl Ed). 2022 Nov;46(9):521-530. doi: 10.1016/j.acuroe.2022.08.013. Epub 2022 Aug 6.
PMID:36216762
Pathology of superficial bladder cancer with emphasis on carcinoma in situ.
Weinstein RS, Coon JS, Schwartz D, Miller AW 3rd, Pauli BU.
Urology. 1985 Oct;26(4 Suppl):2-10.
PMID:3901485
Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
Roumiguié M, Wong A, Belanger E, Wang G, Black PC.
Urol Oncol. 2023 May;41(5):254.e9-254.e15. doi: 10.1016/j.urolonc.2022.10.033. Epub 2022 Dec 22.
PMID:36566105
Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art.
Williamson SR, Montironi R, Lopez-Beltran A, MacLennan GT, Davidson DD, Cheng L.
Crit Rev Oncol Hematol. 2010 Nov;76(2):112-26. doi: 10.1016/j.critrevonc.2010.01.005. Epub 2010 Jan 25.
PMID:20097572
Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.
Tränkenschuh W, Biesdorf AS, Papadimas N, Samara S, Hefty R, Stahl PR.
Int J Surg Pathol. 2019 Sep;27(6):684-692. doi: 10.1177/1066896919839781. Epub 2019 Apr 8.
PMID:30955388
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
Isfoss BL.
BJU Int. 2011 Dec;108(11):1703-7. doi: 10.1111/j.1464-410X.2011.10485.x. Epub 2011 Jul 20.
PMID:21777364
[Carcinoma in situ of the urinary bladder--definition and status of treatment].
Otto T, Rübben H.
Urologe A. 1991 May;30(3):163-6.
PMID:1871934
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3